Houlihan Lokey Advises Astorg

Houlihan Lokey Advises Astorg

Christian Keller Christian Keller

Christian Keller

Co-Head European Financial Sponsors Group at Houlihan Lokey

发布日期: 2022年5月12日
+ 关注

Houlihan Lokey is pleased to announce that Astorg has signed a binding agreement to acquire CordenPharma from International Chemical Investors Group. CordenPharma is a leading global pharmaceutical CDMO (Contract Development & Manufacturing Organization) with highly differentiated capabilities in Active Pharmaceutical Ingredients, Excipients and Drug Products. As part of the transaction, the founders will take the opportunity to reinvest as partners with Astorg. Astorg will work with CordenPharma to further accelerate growth through both organic and external initiatives. The transaction was announced on 2 May 2022, and completion is subject to customary closing conditions

要查看或添加评论，请登录

Christian Keller的更多文章

  • Houlihan Lokey Advises Equistone
    2019年8月15日

    Houlihan Lokey Advises Equistone

    Houlihan Lokey is pleased to announce that its Capital Markets Group has successfully arranged a fully committed debt…

    6 条评论

社区洞察

其他会员也浏览了